Company patents

NCAN Genomics, Inc.

NCAN Genomics, Inc. is entirely focused on Genetic & Microbiological Assays, representing 100.0% of its 36-patent portfolio. While this core area saw explosive growth in 2024 (+1200.0% YoY) and continued expansion in 2025 (+23.1% YoY), the 6 patents so far in 2026 suggest a potential shift or slowdown compared to prior full years.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

36 US filings (since 2023) · 1 categories · 4 themes

Patents

Showing 1-10 of 40

Page 1 of 4